Actively Recruiting

Phase Not Applicable
Age: 1Year - 10Years
All Genders
NCT07068126

Management of Children With Persistent ITP, A Novel Approach

Led by Assiut University · Updated on 2025-07-16

20

Participants Needed

3

Research Sites

60 weeks

Total Duration

On this page

Sponsors

A

Assiut University

Lead Sponsor

Z

Zagazig University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if mini-pool intravenous immunoglobulin (IVIG) is a safe and effective treatment for children with persistent immune thrombocytopenia (ITP). ITP is a condition that causes low platelet levels and increases the risk of bleeding. The main questions this study aims to answer are: Can mini-pool IVIG raise platelet levels in children with persistent ITP? Can it reduce bleeding episodes and hospital visits? What side effects, if any, are seen with this treatment? There is no comparison group in this study. All participants will receive mini-pool IVIG, which is made from small pools of donated plasma using a cost-effective process. Participants will: Receive one dose of mini-pool IVIG through a vein over 6 to 8 hours Receive follow-up doses every 2 to 4 weeks for up to 5 doses, based on their platelet count Have regular blood tests and checkups during the study and for 6 months after treatment Report on bleeding episodes, physical activity, school attendance, and side effects

CONDITIONS

Official Title

Management of Children With Persistent ITP, A Novel Approach

Who Can Participate

Age: 1Year - 10Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 1 to 10 years
  • Male or female gender
  • Diagnosis of persistent immune thrombocytopenia (ITP) according to ASH definition
  • No previous treatment with thrombopoietin agonists
Not Eligible

You will not qualify if you...

  • History of severe adverse reactions to intravenous immunoglobulin (IVIG)
  • Previous history of intracranial hemorrhage (ICH)
  • Difficult venous access
  • Presence of congenital thrombocytopenia, secondary ITP, or non-immune thrombocytopenia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Children's hospital - Assiut University

Asyut, Egypt, 71515

Actively Recruiting

2

Ain Shams University

Cairo, Egypt, 11566

Actively Recruiting

3

Zagazig University, Pediatric departement

Zagazig, Egypt, 44519

Actively Recruiting

Loading map...

Research Team

M

Mohsen El Alfy, Professor

CONTACT

L

Laila M Sherief, Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here